A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : cSCC / cutaneous squamous cell carcinoma

[Related PubMed/MEDLINE]
Total Number of Papers: 579
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   cSCC  (>> Co-occurring Abbreviation)
Long Form:   cutaneous squamous cell carcinoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas. RDEB
2020 A comprehensive analysis of coding and non-coding transcriptomic changes in cutaneous squamous cell carcinoma. circRNAs, lncRNAs
2020 A feasibility study of microwave therapy for precancerous actinic keratosis. AK, AKs
2020 A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis. ---
2020 Artificial neural networks allow response prediction in squamous cell carcinoma of the scalp treated with radiotherapy. ANNs, Gy
2020 Association between PD-L1 expression and lymph node metastasis in cutaneous squamous cell carcinoma. ICs, PD-L1, TCs
2020 Avicularin inhibits cell proliferation and induces cell apoptosis in cutaneous squamous cell carcinoma. AL, EMT, MEK, MMP
2020 AXIN2 and SNAIL expression predict the risk of recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery. AXIN2, MMS
2020 beta-HPV 8E6 Attenuates LATS Phosphorylation After Failed Cytokinesis. beta-HPVs, cSCCs, HP
10  2020 CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma. CASE
11  2020 Cetuximab is efficient and safe in patients with advanced cutaneous squamous cell carcinoma: a retrospective, multicentre study. DCR, ORR, OS, PFS
12  2020 Cutaneous Photoprotection: A Review of the Current Status and Evolving Strategies. BCC, FDA, OTC, UVR
13  2020 Cutaneous squamous cell carcinoma in the organ transplant recipient. SOTRs
14  2020 Cutaneous Squamous Cell Carcinoma: From Biology to Therapy. ---
15  2020 Cutaneous Ultrasound for Tumor Thickness Measurement in Squamous Cell Carcinoma: The Effect of Neoadjuvant Intralesional Methotrexate in 40 Patients. il-MTX
16  2020 Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma. ---
17  2020 DEFINITION OF PROGNOSTIC SUBGROUPS IN THE T3-AJCC8 STAGE FOR CUTANEOUS SQUAMOUS CELL CARCINOMA: TENTATIVE T3 STAGE SUBCLASSIFICATION. DSPO
18  2020 Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline. BCC, RT
19  2020 Detection of human papillomaviruses in paired healthy skin and actinic keratosis by next generation sequencing. AK, HPVs, HS, NGS
20  2020 Downregulation of kynureninase restrains cutaneous squamous cell carcinoma proliferation and represses the PI3K/AKT pathway. KYNU, PI3K, siRNA
21  2020 European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention. AJCC, BWH, CT, EADO, EDF, EORTC, MRI, PET-CT, UICC
22  2020 European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment. ---
23  2020 Evaluation of the utility of localized adjuvant radiation for node-negative primary cutaneous squamous cell carcinoma with clear histologic margins. LCNI, SM
24  2020 Evaluation of Tumor Interstitial Fluid-Extraction Methods for Proteome Analysis: Comparison of Biopsy Elution versus Centrifugation. TIF
25  2020 Expression of the hippo signalling pathway effector YAP during canine epidermal tumourigenesis. CP
26  2020 Facial cutaneous squamous cell carcinoma - microscopic safety margins and their impact on developing local recurrences. LR, mCMD
27  2020 FBXO25 promotes cutaneous squamous cell carcinoma growth and metastasis via cyclin D1. FBPs, SCF
28  2020 H-Ras activation and fibroblast-induced TGF-beta signaling promote laminin-332 accumulation and invasion in cutaneous squamous cell carcinoma. TGF-beta
29  2020 High Hydrostatic Pressure Therapy Annihilates Squamous Cell Carcinoma in a Murine Model. HHP
30  2020 Identification of cases and estimate of direct costs of unresectable and advanced cutaneous squamous cell carcinoma: real-world data from a large Italian database. ---
31  2020 Immunologic Characteristics of Nonmelanoma Skin Cancers: Implications for Immunotherapy. BCC, MCC, NMSCs
32  2020 Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma. 40-GEP, NCCN
33  2020 Inhibition of ROS-NF-kappaB-dependent autophagy enhances Hypocrellin A united LED red light-induced apoptosis in squamous carcinoma A431 cells. HA, NAC, NF-kappaB, ROS
34  2020 Integrated photoacoustic and hyperspectral dual modality microscope for co-imaging of melanoma and cutaneous squamous cell carcinoma in vivo. MM, PAHSM
35  2020 Integrating gene expression profiling into NCCN high-risk cutaneous squamous cell carcinoma management recommendations: impact on patient management. 40-GEP, AJCC, BWH, NCCN
36  2020 Is high-risk cutaneous squamous cell carcinoma of the head and neck a suitable candidate for current targeted therapies? HNcSCC, VAFs
37  2020 Kallikrein-related Peptidase 5 (KLK5) Expression and Distribution in Canine Cutaneous Squamous Cell Carcinoma. KLK5
38  2020 Keratinocyte cancer with incidental perineural invasion: A registry analysis of management and 5-year outcomes. BCC
39  2020 Kidney retransplantation after anti-programmed cell death-1 (PD-1)-related allograft rejection. PD-1
40  2020 Long-standing morphea and the risk of squamous cell carcinoma of the skin. ---
41  2020 Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study. LR, MS, NM
42  2020 LSD1: a viable therapeutic target in cutaneous squamous cell carcinoma? ---
43  2020 Magnetic Resonance Imaging Findings Differentiating Cutaneous Basal Cell Carcinoma from Squamous Cell Carcinoma in the Head and Neck Region. CBCC, MR
44  2020 Making sense of Cbp/p300 loss of function mutations in skin tumorigenesis. ---
45  2020 Measurement of Tumor Thickness in Cutaneous Squamous Cell Carcinomas: Do the Different Methods Provide Better Prognostic Data? RFS
46  2020 Metastatic Cutaneous Squamous Cell Carcinoma in Liver Successfully Treated With Partial Hepatectomy and Adjuvant Irinotecan Chemotherapy. ---
47  2020 MicroRNA-125b exerts antitumor functions in cutaneous squamous cell carcinoma by targeting the STAT3 pathway. miR-125b, STAT3
48  2020 MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling. CD44ICD, cSCCSCs, CSCs
49  2020 miRNAs in the Diagnosis and Prognosis of Skin Cancer. MCC, miRNAs
50  2020 Molecular Approach to Cutaneous Squamous Cell Carcinoma: From Pathways to Therapy. ---
51  2020 Molecular prediction of metastasis in cutaneous squamous cell carcinoma. ---
52  2020 Multiparametric analysis of the effectiveness of cisplatin on cutaneous squamous carcinoma cellsusing two different types of adjuvants. AuNP, CisPt
53  2020 Oncogenic ALK F1174L drives tumorigenesis in cutaneous squamous cell carcinoma. ALK
54  2020 OVOL2-Mediated ZEB1 Downregulation May Prevent Promotion of Actinic Keratosis to Cutaneous Squamous Cell Carcinoma. AK, EMT, OVOL1, OVOL2, ZEB1
55  2020 p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling. lncRNAs, MMP, PRECSIT
56  2020 Pattern of response of unresectable and metastatic cutaneous squamous cell carcinoma to programmed death-1 inhibitors: A review of the literature. FDA, NMSC, PD-1
57  2020 Periorbital squamous cell carcinoma with simultaneous adenocarcinoma in the right orbit. ---
58  2020 Prognostic value of inositol polyphosphate-5-phosphatase expression in recurrent and metastatic cutaneous squamous cell carcinoma. INPP5A, OS
59  2020 Prognostic Value of Tumor Staging: Predicting Nodal Metastases in Cutaneous Squamous Cell Carcinoma. BWH
60  2020 Proteomics: An emerging approach for the diagnosis and classification of cutaneous squamous cell carcinoma and its precursors. AK, BD, KSL
61  2020 Rate of growth-A novel surrogate marker for high-risk cutaneous squamous cell carcinoma? A case report and review of the literature. ROG
62  2020 Recent and Emerging Therapies for Cutaneous Squamous Cell Carcinomas of the Head and Neck. MMS
63  2020 Restaging [18F] fludeoxyglucose positron emission tomography/computed tomography scan in recurrent cutaneous squamous cell carcinoma: Diagnostic performance and prognostic significance. ---
64  2020 Risk factors for recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery: A retrospective review of 237 Asian patients. MMS
65  2020 S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) - short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow-up, prevention and occupational disease. AKs
66  2020 S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma - short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators. AK
67  2020 Sex-specific differences in patients with nonmelanoma skin cancer of the pinna. BCC, NMSC
68  2020 Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032. HI-TOPK-032, NMSC, SUV, TOPK
69  2020 Systemic treatment of patients with advanced cutaneous squamous cell carcinoma: response rates and outcomes of the regimes used. acSCC, nSCC, OS, PFS, RCT
70  2020 The Role of Beta HPV Types and HPV-Associated Inflammatory Processes in Cutaneous Squamous Cell Carcinoma. HPV
71  2020 The Roles of lncRNA in Cutaneous Squamous Cell Carcinoma. ---
72  2020 The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and induces tumorigenic properties. ---
73  2020 Therapeutic effects of ephrin B receptor 2 inhibitors screened by molecular docking on cutaneous squamous cell carcinoma. EphB2
74  2020 Tumor-Suppressive MicroRNA-216b Binds to TPX2, Activating the p53 Signaling in Human Cutaneous Squamous Cell Carcinoma. miR-216b, miRNAs, MTT, qRT-PCR, TPX2
75  2020 Tumour Budding Is an Independent Predictive Factor of Cutaneous Squamous-cell Carcinoma Aggressiveness. HPF, TB
76  2020 Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma. ---
77  2020 Unique spectral signature of human cutaneous squamous cell carcinoma by photoacoustic imaging. PA
78  2020 Update on the anti-programmed cell death-1 receptor antibodies in advanced cutaneous squamous-cell carcinoma. anti-PD-1, EGFR, ICI
79  2020 Validation of a 40-Gene Expression Profile Test to Predict Metastatic Risk in Localized High-Risk Cutaneous Squamous Cell Carcinoma. 40-GEP, GEP, MFS, PPV
80  2020 Voriconazole enhances UV-induced DNA damage by inhibiting catalase and promoting oxidative stress. ---
81  2020 Where do we stand with immune checkpoint blockade for advanced cutaneous squamous cell carcinoma? A systematic review and critical appraisal of the existing evidence. ICB
82  2019 A novel case of cutaneous squamous cell carcinoma at the site of previous sporotrichosis. ---
83  2019 A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing. STR
84  2019 Actinic Keratosis and Cutaneous Squamous Cell Carcinoma. AK
85  2019 Advanced cutaneous squamous cell carcinoma: how is it defined and what new therapeutic approaches are available? ---
86  2019 Advanced cutaneous squamous cell carcinoma: real world data of patient profiles and treatment patterns. acSCC, mOS
87  2019 An assessment of histological margins and recurrence of completely excised cutaneous SCC. ---
88  2019 Approaches to Perineural, Lymphovascular, and Single-Cell Disease. BCC, LVI, MAC, PNI, SCS
89  2019 Association of Adjuvant Radiation Therapy With Survival in Patients With Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck. DFS, HR, OS, PNI
90  2019 Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck. ---
91  2019 Beta Human Papillomavirus and Associated Diseases. HPV, UVR
92  2019 Brain metastasis from cutaneous squamous cell carcinoma coexistent with extramammary Paget's disease: A case report. EMPD
93  2019 Case report of a 65-year-old man with biatrial metastatic localisation from poorly differentiated cutaneous squamous cell carcinoma. SCC
94  2019 Case Report: Cetuximab use in advanced cutaneous squamous cell carcinoma resistant to chemotherapy. EGFR
95  2019 CCL8 enhances sensitivity of cutaneous squamous cell carcinoma to photodynamic therapy by recruiting M1 macrophages. ALA, PDT
96  2019 CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/beta‑catenin signaling pathway. CDC20
97  2019 Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma. FDA
98  2019 Cemiplimab-rwlc as first and only treatment for advanced cutaneous squamous cell carcinoma. FDA, PD-1
99  2019 Cetuximab as a Component of Multimodality Treatment of High-Risk Cutaneous Squamous Cell Carcinoma: A Retrospective Analysis From a Single Tertiary Academic Medical Center. ---
100  2019 Characteristics of Patients Hospitalized for Cutaneous Squamous Cell Carcinoma. LOS